Elevated plasma cholesterol does not affect brain Aβ in mice lacking the low-density lipoprotein receptor

Journal of Neurochemistry

Volumn 102, Issue 4, 2007, Pages 1220-1231

  Elder, Gregory A ^a,b   Cho, Julie Y ^a   English, Daniel F ^a   Franciosi, Sonia ^a   Schmeidler, James ^a   Sosa, Miguel A Gama ^a,b   Gasperi, Rita De ^a,b   Fisher, Edward A ^c   Mathews, Paul M ^c,d   Haroutunian, Vahram ^a   Buxbaum, Joseph D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dietary cholesterol and fat; Low density lipoprotein receptor; Null mutation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CHOLESTEROL; FAT; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CARBOXY TERMINAL SEQUENCE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; GENE MUTATION; LIPID DIET; MALE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEINS E; BRAIN; CHOLESTEROL; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS; MUS MUSCULUS;

EID: 34547479274     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04614.x     Document Type: Article

References (59)

1. Bales K. R., Verina T., Dodel R. C. et al. (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263 264.
2. Beeri M. S., Rapp M., Silverman J. M. et al. (2006) Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology 66, 1399 1404.
3. Breslow J. L. (1996) Mouse models of atherosclerosis. Science 272, 685 688.
4. Breteler M. M. (2000) Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol. Aging 21, 153 160.
5. Burns M., Gaynor K., Olm V., Mercken M., LaFrancois J., Wang L., Mathews P. M., Noble W., Matsuoka Y. Duff K. (2003) Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. J. Neurosci. 23, 5645 5649.
6. Buxbaum J. D., Gandy S. E., Cicchetti P., Ehrlich M. E., Czernik A. J., Fracasso R. P., Ramabhadran T. V., Unterbeck A. J. Greengard P. (1990) Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl Acad. Sci. USA 87, 6003 6006.
7. Cao D., Fukuchi K. I., Wan H., Kim H. Li L. (2006) Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol. Aging 27, 1632 1643.
8. Casserly I. Topol E. (2004) Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139 1146.
9. Dehouck B., Fenart L., Dehouck M. P., Pierce A., Torpier G. Cecchelli R. (1997) A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J. Cell Biol. 138, 877 889.
10. Dietschy J. M. Turley S. D. (2001) Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12, 105 112.
11. Edmond J., Korsak R. A., Morrow J. W., Torok-Both G. Catlin D. H. (1991) Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J. Nutr. 121, 1323 1330.
12. Eichner J. E., Dunn S. T., Perveen G., Thompson D. M., Stewart K. E. Stroehla B. C. (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 155, 487 495.
13. Fagan A. M., Christopher E., Taylor J. W. et al. (2004) ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis. Am. J. Pathol. 165, 1413 1422.
14. Fryer J. D., Demattos R. B., McCormick L. M. et al. (2005) The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. J. Biol. Chem. 280, 25 754 25 759.
15. George A. J., Holsinger R. M., McLean C. A., Laughton K. M., Beyreuther K., Evin G., Masters C. L. Li Q. X. (2004) APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease. Neurobiol. Dis. 16, 124 132.
16. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154 159.
17. Herz J. Bock H. H. (2002) Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71, 405 434.
18. Hofmann S. L., Russell D. W., Goldstein J. L. Brown M. S. (1987) mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. Proc. Natl Acad. Sci. USA 84, 6312 6316.
19. Holtzman D. M., Fagan A. M., Mackey B., Tenkova T., Sartorius L., Paul S. M., Bales K., Ashe K. H., Irizarry M. C. Hyman B. T. (2000a) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47, 739 747.
20. Holtzman D. M., Bales K. R., Tenkova T. et al. (2000b) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 97, 2892 2897.
21. Howland D. S., Trusko S. P., Savage M. J. et al. (1998) Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J. Biol. Chem. 273, 16 576 16 582.
22. Hutter-Paier B., Huttunen H. J., Puglielli L. et al. (2004) The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44, 227 238.
23. Ishibashi S., Brown M. S., Goldstein J. L., Gerard R. D., Hammer R. E. Herz J. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883 893.
24. Ishibashi S., Goldstein J. L., Brown M. S., Herz J. Burns D. K. (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93, 1885 1893.
25. Jurevics H. Morell P. (1995) Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64, 895 901.
26. Kalmijn S., Launer L. J., Ott A., Witteman J. C., Hofman A. Breteler M. M. (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42, 776 782.
27. Kamada H., Hayashi T., Sato K., Iwai M., Nagano I., Shoji M. Abe K. (2005) Up-regulation of low-density lipoprotein receptor expression in the ischemic core and the peri-ischemic area after transient MCA occlusion in rats. Mol. Brain Res. 134, 181 188.
28. Knowles J. W. Maeda N. (2000) Genetic modifiers of atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 20, 2336 2345.
29. Levin-Allerhand J. A., Lominska C. E. Smith J. D. (2002) Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J. Nutr. Health Aging 6, 315 319.
30. Li L., Cao D., Garber D. W., Kim H. Fukuchi K. (2003) Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. Am. J. Pathol. 163, 2155 2164.
31. Lucarelli M., Borrelli V., Fiori A., Cucina A., Granata F., Potenza R. L., Scarpa S., Cavallaro A. Strom R. (2002) The expression of native and oxidized LDL receptors in brain microvessels is specifically enhanced by astrocytes-derived soluble factor(s). FEBS Lett. 522, 19 23.
32. Markwell M. A., Haas S. M., Bieber L. L. Tolbert N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206 210.
33. Mulder M., Jansen P. J., Janssen B. J., van de Berg W. D., van der Boom H., Havekes L. M., de Kloet R. E., Ramaekers F. C. Blokland A. (2004) Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol. Dis. 16, 212 219.
34. Palinski W., Tangirala R. K., Miller E., Young S. G. Witztum J. L. (1995) Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1569 1576.
35. Panza F., D'Introno A., Colacicco A. M., Capurso C., Pichichero G., Capurso S. A., Capurso A. Solfrizzi V. (2006) Lipid metabolism in cognitive decline and dementia. Brain Res. Rev. 51, 275 292.
36. Park I. H., Hwang E. M., Hong H. S., Boo J. H., Oh S. S., Lee J., Jung M. W., Bang O. Y., Kim S. U. Mook-Jung I. (2003) Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol. Aging 24, 637 643.
37. Petanceska S. S., DeRosa S., Olm V., Diaz N., Sharma A., Thomas-Bryant T., Duff K., Pappolla M. Refolo L. M. (2002) Statin therapy for Alzheimer's disease: will it work J. Mol. Neurosci. 19, 155 161.
38. Pitas R. E., Boyles J. K., Lee S. H., Hui D. Weisgraber K. H. (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262, 14 352 14 360.
39. Powell-Braxton L., Veniant M., Latvala R. D., Hirano K. I., Won W. B., Ross J., Dybdal N., Zlot C. H., Young S. G. Davidson N. O. (1998) A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat. Med. 4, 934 938.
40. Quan G., Xie C., Dietschy J. M. Turley S. D. (2003) Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Dev. Brain Res. 146, 87 98.
41. Refolo L. M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G. S., Sambamurti K., Duff K. Pappolla M. A. (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321 331.
42. Refolo L. M., Pappolla M. A., LaFrancois J. et al. (2001) A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8, 890 899.
43. Schmidt S. D., Nixon R. A. Mathews P. M. (2005a) ELISA method for measurement of amyloid-beta levels. Methods Mol. Biol. 299, 279 297.
44. Schmidt S. D., Jiang Y., Nixon R. A. Mathews P. M. (2005b) Tissue processing prior to protein analysis and amyloid-beta quantitation. Methods Mol. Biol. 299, 267 278.
45. Shie F. S., Jin L. W., Cook D. G., Leverenz J. B. LeBoeuf R. C. (2002) Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 13, 455 459.
46. Shimada M., Ishibashi S., Inaba T., Yagyu H., Harada K., Osuga J. I., Ohashi K., Yazaki Y. Yamada N. (1996) Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc. Natl Acad. Sci. USA 93, 7242 7246.
47. Shobab L. A., Hsiung G. Y. Feldman H. H. (2005) Cholesterol in Alzheimer's disease. Lancet Neurol. 4, 841 852.
48. Sjogren M., Mielke M., Gustafson D., Zandi P. Skoog I. (2006) Cholesterol and Alzheimer's disease-is there a relation? Mech. Ageing Dev. 127, 138 147.
49. Snowdon D. A., Greiner L. H., Mortimer J. A., Riley K. P., Greiner P. A. Markesbery W. R. (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813 817.
50. Sparks D. L., Scheff S. W., Hunsaker J. C. 3rd., Liu H., Landers T. Gross D. R. (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88 94.
51. Sparks D. L., Martins R. Martin T. (2002) Cholesterol and cognition: rationale for the AD cholesterol-lowering treatment trial and sex-related differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits. Ann. NY Acad. Sci. 977, 356 366.
52. Swanson L. W., Simmons D. M., Hofmann S. L., Goldstein J. L. Brown M. S. (1988) Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization. Proc. Natl Acad. Sci. USA 85, 9821 9825.
53. Teupser D., Persky A. D. Breslow J. L. (2003) Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6 J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler. Thromb. Vasc. Biol. 23, 1907 1913.
54. Turley S. D., Burns D. K., Rosenfeld C. R. Dietschy J. M. (1996) Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. J. Lipid Res. 37, 1953 1961.
55. Turley S. D., Spady D. K. Dietschy J. M. (1997) Regulation of fecal bile acid excretion in male golden Syrian hamsters fed a cereal-based diet with and without added cholesterol. Hepatology 25, 797 803.
56. Ujiie M., Dickstein D. L., Carlow D. A. Jefferies W. A. (2003) Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10, 463 470.
57. Wilson C., Wardell M. R., Weisgraber K. H., Mahley R. W. Agard D. A. (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252, 1817 1822.
58. Wolozin B. (2004a) Cholesterol, statins and dementia. Curr. Opin. Lipidol. 15, 667 672.
59. Wolozin B. (2004b) Cholesterol and the biology of Alzheimer's disease. Neuron 41, 7 10.